Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans

被引:9
作者
Fagerberg, B
Wiklund, O
Agewall, S
Camejo, G
Wikstrand, RJ
机构
[1] ASTRA HASSLE AB, PRECLIN RES LABS, BIOCHEM, MOLNDAL, SWEDEN
[2] GOTHENBURG UNIV, SAHLGRENS UNIV HOSP, WALLENBERG LAB CARDIOVASC RES, S-41345 GOTHENBURG, SWEDEN
关键词
atherosclerosis; diet; hyperlipidaemia; hypertension; intervention; proteoglycan;
D O I
10.1046/j.1365-2362.1996.2030543.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this work was to examine in an open, randomized parallel-group study whether an intervention programme directed towards hypercholesterolaemia, smoking and diabetes mellitus in treated hypertensive men was associated with less complex formation between low-density lipoprotein (LDL) and human arterial proteoglycans than was the case with usual care. The intervention consisted mainly of non-pharmacological treatment, but drug therapy could be instituted to achieve the treatment goals in the intervention group. The intervention programme was associated with a significant reduction in body mass index, and 46% of the patients were on lipid-lowering medication at the follow-up examination. The net differences were (intervention - usual care): change in serum LDL-cholesterol, -0.48 mmol L(-1) (95% confidence interval -0.84 to -0.11 mmol L(-1)), precipitated LDL-cholesterol, -5.5 mu g (95% CI -9.0 to -1.1 mu g). The latter remained after adjustment for the difference in serum LDL-cholesterol between the groups. Our conclusion is that the multifactorial risk factor treatment programme was associated,with a reduced tendency of LDL to form complexes with human arterial proteoglycans.
引用
收藏
页码:960 / 965
页数:6
相关论文
共 23 条
[1]   THE EFFICACY OF MULTIPLE RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN DURING LONG-TERM FOLLOW-UP [J].
AGEWALL, S ;
WIKSTRAND, J ;
SAMUELSSON, O ;
PERSSON, B ;
ANDERSSON, OK ;
FAGERBERG, B .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) :651-659
[2]   MICROALBUMINURIA, INSULIN SENSITIVITY AND HEMOSTATIC FACTORS IN NONDIABETIC TREATED HYPERTENSIVE MEN [J].
AGEWALL, S ;
FAGERBERG, B ;
ATTVALL, S ;
LJUNGMAN, S ;
URBANAVICIUS, V ;
TENGBORN, L ;
WIKSTRAND, J .
JOURNAL OF INTERNAL MEDICINE, 1995, 237 (02) :195-203
[3]  
AGEWALL S, 1993, NUTR METAB CARDIOVAS, V3, P128
[4]   SMOKING INDUCES INSULIN RESISTANCE - A POTENTIAL LINK WITH THE INSULIN RESISTANCE SYNDROME [J].
ATTVALL, S ;
FOWELIN, J ;
LAGER, I ;
VONSCHENCK, H ;
SMITH, U .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (04) :327-332
[5]  
AUERBACH BJ, 1990, J LIPID RES, V31, P738
[6]  
BECKMANSUURKULA M, 1991, HYPERTENSION, V17, P661
[7]   CHARACTERIZATION AND PROPERTIES OF A LIPOPROTEIN-COMPLEXING PROTEOGLYCAN FROM HUMAN AORTA [J].
CAMEJO, G ;
LALAGUNA, F ;
LOPEZ, F ;
STAROSTA, R .
ATHEROSCLEROSIS, 1980, 35 (03) :307-320
[8]   INTERACTION OF LOW-DENSITY LIPOPROTEINS WITH ARTERIAL PROTEOGLYCANS - THE ROLE OF CHARGE AND SIALIC-ACID CONTENT [J].
CAMEJO, G ;
LOPEZ, A ;
LOPEZ, F ;
QUINONES, J .
ATHEROSCLEROSIS, 1985, 55 (01) :93-105
[9]   BINDING PARAMETERS AND CONCENTRATION MODULATE FORMATION OF COMPLEXES BETWEEN LDL AND ARTERIAL PROTEOGLYCANS IN SERUM [J].
CAMEJO, G ;
LINDEN, T ;
OLSSON, U ;
WIKLUND, O ;
LOPEZ, F ;
BONDJERS, G .
ATHEROSCLEROSIS, 1989, 79 (2-3) :121-128
[10]  
CAMEJO G, 1990, CURR OPIN LIPIDOL, V1, P431